A phase I-II trial of Ispinesib, a kinesin spindle protein inhibitor, dosed every two weeks in patients with locally advanced or metastatic breast cancer previously untreated with chemotherapy for metastatic disease or recurrence.

被引：0
|
作者：
Gomez, H.
Castaneda, C.
Philco, M.
Pimentel, P.
Falcon, S.
Escandon, R.
Saikali, K.
Conlan, M.
Seroogy, J.
Wolff, A.
机构：
[1] Inst Nacl Enfermedades Neoplasicas, Lima, Peru
[2] Hosp Nacl Alberto Sabogal Sologuren, Lima, Peru
[3] Hosp Nacl Edgardo Rebagliati Martins, Lima, Peru
[4] Cytokinet Inc, San Francisco, CA USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：199S / 200S
页数：2
相关论文
共 50 条
  • [41] Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapy
    Blum, Joanne L.
    Dees, E. Claire
    Vukelja, Svetislava J.
    Amare, Mammo
    Gill, David P.
    McMahon, Richard T.
    Ilegbodu, Des
    Asmar, Lina
    O'Shaughnessy, Joyce A.
    CLINICAL BREAST CANCER, 2007, 7 (06) : 465 - 470
  • [42] Phase I dose-escalation and pharmacokinetic study of ispinesib, a kinesin spindle protein inhibitor, administered on days 1 and 15 of a 28-day schedule in patients with no prior treatment for advanced breast cancer
    Gomez, Henry L.
    Philco, Manuel
    Pimentel, Patricia
    Kiyan, Miriam
    Monsalvo, Maria Laura
    Conlan, Maureen G.
    Saikali, Khalil G.
    Chen, Michael M.
    Seroogy, Joseph J.
    Wolff, Andrew A.
    Escandon, Rafael D.
    ANTI-CANCER DRUGS, 2012, 23 (03) : 335 - 341
  • [43] A phase I-II trial of the kinesin spindle protein (KSP) inhibitor SB-743921 on days 1 and 15 every 28 days in non-Hodgkin or Hodgkin lymphoma
    O'Connor, O. A.
    Goy, A.
    Orlowski, R.
    Hainsworth, J. D.
    Leonard, J. P.
    Afanasyev, B.
    Osmanov, D.
    Chen, M.
    Wolff, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] A phase I-II trial of the kinesin spindle protein (KSP) inhibitor SB-743921 ondays 1 and 15 every 28 days in non-Hodgkin or Hodgkin lymphoma
    O'Connor, O.
    ANNALS OF ONCOLOGY, 2008, 19 : 162 - 163
  • [45] Preliminary results of a phase II trial of irinotecan (I) and gemcitabine (G) in patients with locally advanced or metastatic bladder cancer.
    Chaudhary, U
    Shannon, S
    Curry, N
    Keane, TE
    Means, RT
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (01) : S293 - S293
  • [46] Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer
    Bendell, Johanna
    Saleh, Mansoor
    Rose, April A. N.
    Siegel, Peter M.
    Hart, Lowell
    Sirpal, Surendra
    Jones, Suzanne
    Green, Jennifer
    Crowley, Elizabeth
    Simantov, Ronit
    Keler, Tibor
    Davis, Thomas
    Vahdat, Linda
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (32) : 3619 - +
  • [47] RANDOMIZED PHASE II TRIAL WITH AN UPA INHIBITOR (WX-671) IN PATIENTS WITH LOCALLY ADVANCED NON-METASTATIC PANCREATIC CANCER
    Heinemann, V.
    Ebert, M.
    Pinter, T.
    Mala, C.
    Neville, N.
    Bevan, P.
    ANNALS OF ONCOLOGY, 2010, 21 : 226 - 226
  • [48] A phase II study of intravenous DX-8951f administered daily for five days every three weeks to patients with previously untreated metastatic gastric cancer.
    Becerra, CR
    Takimoto, C
    Ajani, JA
    Major, P
    Feit, K
    Duggal, A
    De Jagger, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 344S - 344S
  • [49] Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: BIBABRAX study.
    Feliu Batlle, Jaime
    Jorge Fernandez, Monica
    Macarulla, Teresa
    Massuti, Bartomeu
    Albero, Ana
    Gonzalez, Federico
    Quintero Aldana, Guillermo Alfonso
    Delgado Mingorance, J. Ignacio
    Fernandez Montes, Ana
    Garcia Piernavieja, Carmen
    Valladares-Ayerbes, Manuel
    Garcia Giron, Carlos
    Mondejar, Rebeca
    Vicente, Pilar
    Casado, Esther
    Gonzalez Cebrian, Irene
    Lopez-Vivanco, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck
    Posner, MR
    Glisson, B
    Frenette, G
    Al-Sarraf, M
    Colevas, AD
    Norris, CM
    Seroskie, JD
    Shin, DM
    Olivares, R
    Garay, CA
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) : 1096 - 1104
12345